In its second-quarter financial filing, Iovance said it was planning to shed 19% of its workforce of more than 630 in order ...

We assume that what worked in the 1950s still works now. We assume that more budget is the only answer. Yet, AI can help in transformative ways if adopted at scale. If AI were scaled across the NHS to ...

The complicated legal wrangling has been brought to a close after CureVac and BioNTech settled their mRNA patent litigation ...

The smartphone-based CT-155 app, co-developed by Click Therapeutics and Boehringer Ingelheim, was able to help users achieve ...

Strand Therapeutics has raised $153 million in second-round financing that will be used to move its programmable mRNA ...

Today, the regulator revealed FDA PreCheck, which introduces a two-phase approach to getting approval for new production ...

It was that same signal-based approach that we found can be applied to cancer research. A potential new approach to developing immunotherapies for cancer is built around dialling in to detect, and ...

When it comes to artificial intelligence, the tables are turning and there is a shift in considering it a hype to understanding that AI is a real necessity. And 2025 is becoming a turning point ...

Hundreds of adults and teenagers in England with rare eye disease Leber's hereditary optic neuropathy (LHON) will soon have ...

For comparison, Lilly's arch-rival in the weight-loss category, Novo Nordisk, is developing an oral formulation of ...

The move has thrilled people in the vaccine sceptic community, including Mary Holland, chief executive of Children's Health ...

Jazz Pharmaceuticals has become the first drugmaker to get FDA approval for a treatment for diffuse midline glioma with H3 ...